Current constitutional documents

Click here

Most recent admission document

Click here

Details of Any Other Exchanges or Trading Platforms

The company is not quoted on any other exchanges or trading platforms

Details of any Restrictions on the Transfer of Securities

There are no restrictions on the transfer of Abingdon Health securities

Whether the Company is subject to the UK City Code on Takeovers and Mergers

The company is subject to the UK City Code on Takeovers and Mergers

Country of Incorporation and Main Country of Operation

Abingdon Health was incorporated in England and Wales on 16 January 2008 (Registration No. 06475379) and is headquartered in York, UK, with an additional site in Doncaster.

Number of Securities in Issue

Issued share capital consists of 193,630,821 ordinary shares of 0.025p each.

AIM securities not in public hands

In so far as the Company is aware, the percentage of AIM securities not in public hands is: 21.8%

Significant Shareholders (3% or over)

Shareholder Ordinary Shares Issued Share Capital (%)
Octopus Investments Limited 19,606,013 10.1%
Cannacord Genuity Wealth Mgt 18,702,013 9.7%
Enterprise Ventures (General Partner NPIF YHTV Equity) Ltd / Mercia 18,071,164 9.3%
Rathbones Investment Mgt 13,938,152 7.2%
Chris Hand 13,178,467 6.8%
Hargreaves Lansdown Asset Mgt 11,804,732 6.1%
Chris Yates 7,888,844 4.1%
Interactive Investor 7,350,767 3.8%
Catenalucis LLC 7,088,488 3.7%
Thornapple LLP 6,113,124 3.2%

This information was last updated on 31st March 2025.

Description of business

Click here

Board and Governance

Click here

Documents and Reports

Click here

Regulatory Announcements

Click here

Advisors

Nominated Advisor and Broker:
Zeus Capital Limited
12th Floor, 125 Old Broad Street
London
EC2N 1AR

Solicitors to the Company:
Squire Patton Boggs (UK) LLP
6 Wellington Place
Leeds
LS1 4AP

Reporting Accountant and Auditor:
RSM UK Audit LLP
Fifth Floor
Central Square
29 Wellington Street
Leeds
LS1 4DL

Registrar:
MUFG Corporate Markets
Central Square
29 Wellington St
Leeds
LS1 4DL

Financial Press Office:
For all investor relations enquiries, please contact [email protected].

Latest Investor News

Click here